New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents

dc.contributor.authorVijesh, A.M.
dc.contributor.authorIsloor, A.M.
dc.contributor.authorShetty, P.
dc.contributor.authorSundershan, S.
dc.contributor.authorFun, H.-K.
dc.date.accessioned2026-02-05T09:34:52Z
dc.date.issued2013
dc.description.abstractAzole class of compounds are well known for their excellent therapeutic properties. Present paper describes about the synthesis of three series of new 1,2,4-triazole and benzoxazole derivatives containing substituted pyrazole moiety (11a-d, 12a-d and 13a-d). The newly synthesized compounds were characterized by spectral studies and also by C, H, N analyses. All the synthesized compounds were screened for their analgesic activity by the tail flick method. The antimicrobial activity of the new derivatives was also performed by Minimum Inhibitory Concentration (MIC) by the serial dilution method. The results revealed that the compound 11c having 2,5-dichlorothiophene substituent on pyrazole moiety and a triazole ring showed significant analgesic and antimicrobial activity. © 2012 Elsevier Masson SAS. All rights reserved.
dc.identifier.citationEuropean Journal of Medicinal Chemistry, 2013, 62, , pp. 410-415
dc.identifier.issn2235234
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2012.12.057
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/26808
dc.subjectanalgesic agent
dc.subjectantibiotic agent
dc.subjectantifungal agent
dc.subjectbenzoxazole derivative
dc.subjectceftriaxone
dc.subjectfluconazole
dc.subjectpentazocine
dc.subjectpyrazole derivative
dc.subjectanalgesic activity
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectantibacterial activity
dc.subjectantifungal activity
dc.subjectarticle
dc.subjectBacillus subtilis
dc.subjectCandida albicans
dc.subjectcarbon nuclear magnetic resonance
dc.subjectcontrolled study
dc.subjectdilution
dc.subjectdrug screening
dc.subjectdrug synthesis
dc.subjectEscherichia coli
dc.subjectmale
dc.subjectminimum inhibitory concentration
dc.subjectnitrogen nuclear magnetic resonance
dc.subjectnonhuman
dc.subjectproton nuclear magnetic resonance
dc.subjectPseudomonas aeruginosa
dc.subjectrat
dc.subjectStaphylococcus aureus
dc.subjecttail flick test
dc.subjectAnalgesics
dc.subjectAnimals
dc.subjectAnti-Bacterial Agents
dc.subjectAntifungal Agents
dc.subjectBacteria
dc.subjectBenzoxazoles
dc.subjectDose-Response Relationship, Drug
dc.subjectFungi
dc.subjectMicrobial Sensitivity Tests
dc.subjectMolecular Structure
dc.subjectPain
dc.subjectPain Measurement
dc.subjectPyrazoles
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectStructure-Activity Relationship
dc.subjectTriazoles
dc.titleNew pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents

Files

Collections